DTIL – Precision BioSciences, Inc.
Float Short %
4.2
Margin Of Safety %
Put/Call OI Ratio
0.11
EPS Next Q Diff
1.02
EPS Last/This Y
-7.21
EPS This/Next Y
3.05
Price
4.36
Target Price
32.5
Analyst Recom
1
Performance Q
-23.24
Relative Volume
1.86
Beta
1.31
Ticker: DTIL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-09 | DTIL | 4.85 | 0.97 | 999.99 | 150 |
| 2025-12-10 | DTIL | 5 | 1.04 | 0.00 | 165 |
| 2025-12-11 | DTIL | 4.92 | 0.76 | 0.07 | 195 |
| 2025-12-12 | DTIL | 5.01 | 0.37 | 2.94 | 346 |
| 2025-12-15 | DTIL | 4.8 | 0.55 | 0.00 | 407 |
| 2025-12-16 | DTIL | 4.81 | 0.20 | 0.41 | 860 |
| 2025-12-17 | DTIL | 4.77 | 0.21 | 0.00 | 907 |
| 2025-12-18 | DTIL | 4.53 | 0.21 | 0.46 | 908 |
| 2025-12-19 | DTIL | 4.49 | 0.21 | 999.99 | 918 |
| 2025-12-22 | DTIL | 4.33 | 0.01 | 0.11 | 737 |
| 2025-12-23 | DTIL | 4.29 | 0.01 | 0.11 | 737 |
| 2025-12-26 | DTIL | 4.21 | 0.01 | 0.00 | 741 |
| 2025-12-29 | DTIL | 4.28 | 0.01 | 0.00 | 749 |
| 2025-12-30 | DTIL | 4.38 | 0.01 | 0.00 | 749 |
| 2025-12-31 | DTIL | 4.15 | 0.01 | 0.50 | 764 |
| 2026-01-02 | DTIL | 4.09 | 0.01 | 999.99 | 765 |
| 2026-01-05 | DTIL | 4.1 | 0.05 | 3.91 | 796 |
| 2026-01-06 | DTIL | 4.21 | 0.11 | 0.09 | 839 |
| 2026-01-07 | DTIL | 4.35 | 0.11 | 0.00 | 841 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-09 | DTIL | 4.86 | 66.1 | - | -6.41 |
| 2025-12-10 | DTIL | 5.01 | 66.1 | - | -6.41 |
| 2025-12-11 | DTIL | 4.90 | 66.1 | - | -6.41 |
| 2025-12-12 | DTIL | 5.01 | 69.9 | - | -6.16 |
| 2025-12-15 | DTIL | 4.80 | 69.9 | - | -6.16 |
| 2025-12-16 | DTIL | 4.80 | 69.9 | - | -6.16 |
| 2025-12-17 | DTIL | 4.78 | 69.9 | - | -6.16 |
| 2025-12-18 | DTIL | 4.52 | 69.9 | - | -6.16 |
| 2025-12-19 | DTIL | 4.49 | 69.9 | - | -6.16 |
| 2025-12-22 | DTIL | 4.36 | 69.9 | - | -6.16 |
| 2025-12-23 | DTIL | 4.31 | 69.9 | - | -6.16 |
| 2025-12-26 | DTIL | 4.21 | 69.9 | - | -6.16 |
| 2025-12-29 | DTIL | 4.30 | 69.9 | - | -6.16 |
| 2025-12-30 | DTIL | 4.38 | 69.9 | - | -6.16 |
| 2025-12-31 | DTIL | 4.14 | 69.9 | - | -6.16 |
| 2026-01-02 | DTIL | 4.10 | 69.9 | - | -6.16 |
| 2026-01-05 | DTIL | 4.09 | 69.9 | - | -6.16 |
| 2026-01-06 | DTIL | 4.20 | 69.9 | - | -6.16 |
| 2026-01-07 | DTIL | 4.36 | 69.9 | - | -6.16 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-09 | DTIL | -0.20 | 1.04 | 2.76 |
| 2025-12-10 | DTIL | -0.20 | 1.04 | 3.29 |
| 2025-12-11 | DTIL | -0.20 | 1.04 | 3.29 |
| 2025-12-12 | DTIL | -0.20 | 1.04 | 3.29 |
| 2025-12-15 | DTIL | -0.20 | 1.04 | 3.29 |
| 2025-12-16 | DTIL | -0.20 | 1.04 | 3.29 |
| 2025-12-17 | DTIL | -0.05 | 1.04 | 3.29 |
| 2025-12-18 | DTIL | -0.05 | 1.04 | 3.29 |
| 2025-12-19 | DTIL | -0.05 | 1.04 | 3.29 |
| 2025-12-22 | DTIL | -0.05 | 1.05 | 3.30 |
| 2025-12-23 | DTIL | -0.05 | 1.05 | 3.30 |
| 2025-12-26 | DTIL | -0.05 | 1.05 | 4.20 |
| 2025-12-29 | DTIL | -0.19 | 1.05 | 4.20 |
| 2025-12-30 | DTIL | -0.19 | 1.05 | 4.20 |
| 2025-12-31 | DTIL | -0.19 | 1.05 | 4.20 |
| 2026-01-02 | DTIL | -0.19 | 1.05 | 4.20 |
| 2026-01-05 | DTIL | -0.19 | 1.03 | 4.20 |
| 2026-01-06 | DTIL | -0.19 | 1.03 | 4.20 |
| 2026-01-07 | DTIL | -0.19 | 1.03 | 4.20 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.84
Avg. EPS Est. Current Quarter
-0.64
Avg. EPS Est. Next Quarter
-0.82
Insider Transactions
-0.19
Institutional Transactions
1.03
Beta
1.31
Average Sales Estimate Current Quarter
9
Average Sales Estimate Next Quarter
2
Fair Value
Quality Score
10
Growth Score
31
Sentiment Score
34
Actual DrawDown %
99.1
Max Drawdown 5-Year %
-99.2
Target Price
32.5
P/E
Forward P/E
PEG
P/S
149.93
P/B
3.17
P/Free Cash Flow
EPS
-8.4
Average EPS Est. Cur. Y
-6.16
EPS Next Y. (Est.)
-3.11
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-11977.36
Relative Volume
1.86
Return on Equity vs Sector %
-529.7
Return on Equity vs Industry %
-514.5
EPS 1 7Days Diff
0.3
EPS 1 30Days Diff
0.25
EBIT Estimation
Precision BioSciences, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 67
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-3243 for the treatment of m.3243 associated mitochondrial myopathy. In addition, the company develops PBGENE-NVS (insertion) for sickle cell and beta thalassemia diseases; PBGENE-DMD (excision) for duchenne muscular dystrophy; PBGENE-LIVER (insertion), a liver directed target; PBGENE-CNS (excision), a central nervous system directed target; and iECURE-OTC (insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with Novartis Pharma AG to discover and develop in vivo gene editing products; TG Cell Therapy, Inc. to develop, manufacture, and commercialize azer-cel for autoimmune diseases and other indications outside of cancer; and iECURE, Inc. to develop ARCUS-based gene-insertion therapies. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
stock quote shares DTIL – Precision BioSciences, Inc. Stock Price stock today
news today DTIL – Precision BioSciences, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DTIL – Precision BioSciences, Inc. yahoo finance google finance
stock history DTIL – Precision BioSciences, Inc. invest stock market
stock prices DTIL premarket after hours
ticker DTIL fair value insiders trading